Autosomal dominant polycystic kidney disease: Prevalence of renal neoplasias in surgical kidney specimens

Nephron - Clinical Practice

Volumn 123, Issue 1-2, 2013, Pages 13-21

  Jilg, Cordula A ^a   Drendel, Vanessa ^a   Bacher, Janina ^a   Pisarski, Przemyslaw ^a   Neeff, Hannes ^a   Drognitz, Oliver ^a   Schwardt, Malte ^a   Gläsker, Sven ^a   Malinoc, Angelica ^a   Erlic, Zoran ^a   Nunez, Mercedes ^a,b   Weber, Alexander ^a   Azurmendi, Pablo ^c   Schultze Seemann, Wolfgang ^a   Werner, Martin ^a   Neumann, Hartmut P H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Adult polycystic renal disease; Autosomal dominant polycystic kidney disease; Renal cell cancer; Renal cell carcinoma

Indexed keywords

CREATININE;

ADULT; ARTICLE; BENIGN TUMOR; CANCER RISK; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; KIDNEY SURGERY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; CLEAR CELL CARCINOMA; CREATININE BLOOD LEVEL; DIALYSIS; GERMANY; HISTOPATHOLOGY; INCIDENCE; KIDNEY CYST; KIDNEY METASTASIS; KIDNEY TUMOR; PAPILLARY CARCINOMA; REGISTER; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; GERMANY; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; RENAL DIALYSIS; RISK ASSESSMENT;

EID: 84882429860     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000351049     Document Type: Article

References (23)

1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301.
2. Walters W, Braasch WF: Surgical aspect of polycystic kidney. Surg Obstet Gynecol 1934; 647-650.
3. Keith DS, Torres VE, King BF, Zincki H, Farrow GM: Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 4: 1661-1669.
4. Miwa S, Fuse H, Hirano S, Masuda S: Transitional cell carcinoma of the renal pelvis in a long-term hemodialysis patient with autosomal dominant polycystic kidney. Int J Urol 2001; 8: 572-574.
5. Hama Y, Kaji T, Ito K, Hayakawa M, Tobe M, Kosuda S: Erythropoietin-producing renal cell carcinoma arising from autosomal dominant polycystic kidney disease. Br J Radiol 2005; 78: 269-271.
6. Chang YL, Chung HJ, Chen KK: Bilateral renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease. J Chin Med Assoc 2007; 70: 403-405.
7. Jurgensen JS, Muller V, Kettritz U, Woywodt A, Gobel U, Luft FC: A malignant 'incidentaloma' in a patient with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1999; 14: 490-492.
8. Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, Durrbach A, Droupy S, Benoit G: Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 2009; 74: 631-634.
9. Lane W, Lacefield E, Tran R, Riese W: The clinical association of autosomal dominant polycystic kidney disease and renal cell carcinoma. Open J Urol 2011; 2: 11-14.
10. Bernstein J, Evan AP, Gardner KD Jr: Human cystic kidney diseases: epithelial hyperplasia in the pathogenesis of cysts and tumors. Pediatr Nephrol 1987; 1: 393-396.
11. Gregoire JR, Torres VE, Holley KE, Farrow GM: Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987; 9: 27-38.
12. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K: SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute Bethesda, 2012. http://seercancergov/ csr/1975-2009-pops09/.
13. Orskov B, Sorensen VR, Feldt-Rasmussen B, Strandgaard S: Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant 2012; 27: 1607-1613.
14. Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P: Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003; 14: 197-207.
15. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE: Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
16. Shebl FM, Warren JL, Eggers PW, Engels EA: Cancer risk among elderly persons with endstage renal disease: a population-based casecontrol study. BMC Nephrol 2012; 13: 65.
17. Bonsib SM: Renal cystic diseases and renal neoplasms: a mini-review. Clin J Am Soc Nephrol 2009; 4: 1998-2007.
18. Prasad SR, Humphrey PA, Catena JR, Narra VR, Srigley JR, Cortez AD, Dalrymple NC, Chintapalli KN: Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 2006; 26: 1795-1806.
19. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-624.
20. Hughson MD, Buchwald D, Fox M: Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986; 110: 592-601.
21. Ishikawa I, Kovacs G: High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993; 22: 135-139.
22. DeLong MJ, Schmitt D, Scott KM, Ramakumar S, Lien YH: Multicentric papillary renal carcinoma in renal allograft. Am J Kidney Dis 2003; 42: 381-384.
23. Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y, Coulange C, Lechevallier E: De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005; 103: 251-257.